AFB date | Month | Biopsy site | Diagnosis | AFB status | TP53 status | LoH/RoH (D17S 1881) |
---|---|---|---|---|---|---|
10/2000 | M38 | LUL stump | CIS | + | Mutant | LoH |
LLL orifice (control) | NAD | − | Wildtype | RoH | ||
LLL (control) | NAD | − | Wildtype | RoH | ||
*MC (control) | NAD | − | Wildtype | RoH/RoH | ||
RUL (control) | NAD | − | Wildtype | RoH | ||
RLL (control) | NAD | − | Wildtype | RoH | ||
03/2001 | M43 | LUL stump | SD | + | Mutant | LoH |
07/2001 | M47 | LUL stump | CIS | + | Mutant | LoH |
12/2001 | M51 | LLL (control) | NAD | − | Wildtype | RoH |
01/2003 | M64 | Left main bronchus | SD | + | Mutant | N/A |
07/2003 | M70 | LLL (control) | NAD | − | Wildtype | RoH |
†LLL orifice | SD | + | Mutant | LoH /LoH | ||
Proximal left main bronchus | SD | + | Mutant | LoH | ||
Left main bronchus | CIS | + | Mutant | N/A | ||
11/2003 | M74 | LLL (control) | NAD | − | Wildtype | N/A |
Proximal left main bronchus | CIS | + | Mutant | N/A | ||
05/2004 | M80 | LLL (control) | NAD | − | Wildtype | N/A |
09/2004 | M84 | LLL (control) | NAD | − | Wildtype | N/A |
04/2006 | M104 | MC | CIS | + | Mutant | N/A |
MC (control) | NAD | − | Wildtype | N/A | ||
08/2006 | M108 | Lower anterior trachea | CIS | + | Mutant | LoH |
01/2007 | M113 | Lower lateral trachea | CIS | + | Mutant | LoH |
04/2007 | M116 | Lower trachea | CIS | + | Mutant | N/A |
03/2008 | M127 | RMB (control) | NAD | − | Wildtype | N/A |
RMB | MoD | + | Mutant | N/A | ||
Lower trachea (control) | NAD | − | Wildtype | RoH | ||
08/2008 | M132 | MC/stump | CIS | + | Mutant | N/A |
Proximal RMB medial wall | CIS | + | Mutant | LoH | ||
Proximal RMB medial wall | SD | + | Mutant | N/A | ||
01/2009 | M137 | RMB | CIS | + | Mutant | N/A |
LMB stump | CIS | + | Mutant | LoH | ||
07/2009 | M143 | Lateral wall of orifice to RMB | CIS | + | Mutant | LoH |
Posterior wall proximal RMB | CIS | + | Mutant | LoH | ||
Left pneumonectomy stump | CIS | + | Mutant | LoH | ||
11/2010 | M159 | RMB | MiD | − | Wildtype | RoH |
RMB | Metaplasia | − | Wildtype | RoH | ||
MC | CIS | + | Mutant | LoH | ||
MC | MiD | − | Wildtype | RoH | ||
MC (control) | NAD | − | Wildtype | RoH | ||
RML (control) | NAD | − | Wildtype | RoH | ||
05/2011 | M165 | RML | CIS | + | Mutant | N/A |
03/2012 | M175 | RML | CIS | + | Mutant | N/A |
RLL | CIS | + | Mutant | N/A | ||
08/2012 | M180 | Posterior wall of RMB | SqCC | + | Mutant | N/A |
Month refers to post-lobectomy.
*At M38, two distinct areas of the MC were biopsied, providing two AFB and histology normal samples.
†At M70, two distinct AFB detected and histology-confirmed SD samples from the LLL orifice were analysed and found to carry the c.880delG. In total, 46 samples from 19 spatially distinct areas were analysed over a period of 12 years (M38–M180).
AFB, auto-fluorescence bronchoscopy; CIS, carcinoma in situ; LLL, left lower lobe; LMB, left main bronchus; LoH, loss of heterozygosity; LUL, left upper lobe; MiD, mild dysplasia; MoD, moderate dysplasia; N/A, not analysed due to insufficient DNA lysate; NAD, no abnormality detected; RLL, right lower lobe; RMB, right main bronchus; RML, right middle lobe; RoH, retention of heterozygosity; RUL, right upper lobe; SD, severe dysplasia.